FDA greenlights Boston Scientific’s Novel Drug-Coated Balloon for Coronary In-Stent Restenosis

Boston Scientific’s AGENT™ Drug-Coated Balloon (DCB) has been granted approval by the U.S. Food and Drug Administration (FDA) for treating coronary in-stent restenosis (ISR) in patients with coronary artery disease. While advancements in percutaneous coronary intervention (PCI) technologies are ongoing, recent research indicates that ISR, the gradual re-narrowing of a previously opened coronary artery, still…

Read More

Quitting Cigarettes Before Surgery Risky

Quitting Cigarettes

MONTREAL — Quitting smoking before lung surgery is a good thing, but doing it too soon before the procedure might not be, a researcher said here. In a single-institution cohort, patients who quit smoking within a month of their thoracoscopic lobectomy to treat lung cancer had more complications than those with a longer time off…

Read More

Robotic Surgeries Positioned to Surge Over Next Five Years

U.S. surgeons predict a big increase in robot-assisted surgeries over the next five years, especially for colorectal and hernia procedures, according to a survey by RBC Capital Markets. About 15% of surgeries today involve the use of robots, and the figure could hit 35% in five years and 41% in 10 years, the survey indicates.…

Read More